In addition, the transcription factor NF1A, was recently found to have GBM-promoting effects, which were mediated via transcriptional repression of p53, p21, and PAI1 through specific NFIA-recognition sequences in their promoters [76]. The gene discussed is TP53; the disease is glioblastoma.